RYTM - Rhythm Pharmaceuticals Q4 2023 Earnings Preview
2024-02-21 11:01:15 ET
More on Rhythm Pharmaceuticals
- Rhythm completes screening for Phase 3 anti-obesity study
- Rhythm to acquire rights to Phase 2 anti-obesity drug from LG Chem
- Seeking Alpha’s Quant Rating on Rhythm Pharmaceuticals
- Historical earnings data for Rhythm Pharmaceuticals
- Financial information for Rhythm Pharmaceuticals